1. Home
  2. TNL vs FOLD Comparison

TNL vs FOLD Comparison

Compare TNL & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

HOLD

Current Price

$74.13

Market Cap

4.5B

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.49

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNL
FOLD
Founded
1990
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.5B
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
TNL
FOLD
Price
$74.13
$14.49
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$84.00
$27.25
AVG Volume (30 Days)
778.4K
2.5M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.80%
N/A
EPS Growth
N/A
50.00
EPS
1.22
N/A
Revenue
$4,021,000,000.00
N/A
Revenue This Year
$3.56
$20.50
Revenue Next Year
$3.55
$18.59
P/E Ratio
$60.30
N/A
Revenue Growth
4.06
N/A
52 Week Low
$48.33
$5.66
52 Week High
$81.00
$14.50

Technical Indicators

Market Signals
Indicator
TNL
FOLD
Relative Strength Index (RSI) 66.96 74.18
Support Level $70.31 $14.21
Resistance Level $77.18 N/A
Average True Range (ATR) 1.90 0.02
MACD 0.72 -0.00
Stochastic Oscillator 93.51 100.00

Price Performance

Historical Comparison
TNL
FOLD

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: